NL193267C - Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. - Google Patents

Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. Download PDF

Info

Publication number
NL193267C
NL193267C NL9000428A NL9000428A NL193267C NL 193267 C NL193267 C NL 193267C NL 9000428 A NL9000428 A NL 9000428A NL 9000428 A NL9000428 A NL 9000428A NL 193267 C NL193267 C NL 193267C
Authority
NL
Netherlands
Prior art keywords
filling
mixture
oily excipient
gelatin
ranitidine hydrochloride
Prior art date
Application number
NL9000428A
Other languages
English (en)
Dutch (nl)
Other versions
NL193267B (nl
NL9000428A (nl
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of NL9000428A publication Critical patent/NL9000428A/nl
Publication of NL193267B publication Critical patent/NL193267B/xx
Application granted granted Critical
Publication of NL193267C publication Critical patent/NL193267C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL9000428A 1989-02-23 1990-02-22 Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. NL193267C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8904182 1989-02-23
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NL9000428A NL9000428A (nl) 1990-09-17
NL193267B NL193267B (nl) 1999-01-04
NL193267C true NL193267C (nl) 1999-05-06

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9000428A NL193267C (nl) 1989-02-23 1990-02-22 Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.

Country Status (26)

Country Link
US (1) US5028432A (fr)
JP (1) JP2856817B2 (fr)
KR (1) KR940006271B1 (fr)
AT (1) AT401727B (fr)
AU (1) AU629303B2 (fr)
BE (1) BE1003123A3 (fr)
CA (1) CA2010692C (fr)
CH (1) CH680567A5 (fr)
CY (1) CY1734A (fr)
DE (1) DE4005650C2 (fr)
DK (1) DK170209B1 (fr)
FR (1) FR2643263B1 (fr)
GB (2) GB8904182D0 (fr)
HK (1) HK89493A (fr)
HU (1) HU211930A9 (fr)
IE (1) IE63179B1 (fr)
IL (1) IL93490A (fr)
IT (1) IT1240768B (fr)
LU (1) LU87681A1 (fr)
NL (1) NL193267C (fr)
NZ (1) NZ232642A (fr)
PH (1) PH26972A (fr)
SA (1) SA90100287B1 (fr)
SE (1) SE512412C2 (fr)
ZA (1) ZA901348B (fr)
ZW (1) ZW1790A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0548238A1 (fr) * 1990-09-13 1993-06-30 Smithkline Beecham Corporation Suspensions orales liquides non aqueuses
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
US7423004B2 (en) * 2003-01-31 2008-09-09 Smithkline Beecham Corporation Solid dispersion compositions
WO2005016312A1 (fr) 2003-08-13 2005-02-24 Nobex Corporation Formulation de dosage de solides de sels d'acides gras destinee a des agents therapeutiques
SG185631A1 (en) 2010-06-23 2012-12-28 Colgate Palmolive Co Therapeutic oral composition
EP2654672B1 (fr) 2010-12-20 2017-03-08 Colgate-Palmolive Company Composition pour soin buccal encapsulée dans de la gélatine contenant des actifs occlusifs, des modificateurs de viscosité hydrophobiques et un porteur oléique
EP2654671B1 (fr) 2010-12-20 2019-02-20 Colgate-Palmolive Company Compositions orales non-aqueuses contenant des agents occluant des dents
MX362101B (es) 2010-12-20 2019-01-07 Colgate Palmolive Co Composición de cuidado bucal encapsulada con gelatina que contiene agente de estructura hidrofóbico, ingrediente activo hidrofilico, y portador de aceite.
MA46713A (fr) * 2016-11-01 2019-09-11 Johnson & Johnson Consumer Inc Forme posologique pharmaceutique orale liquide comprenant un antagoniste du récepteur h2 à l'histamine et un antiacide
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (fr) * 1980-05-17 1981-11-25 FISONS plc Mélanges, sels, emballages et compositions pharmaceutiques contenant l'acide 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyrane-2-carboxylique ou un de ses dérivés et une antihistamine antagoniste des récepteurs H2
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
WO1985000516A1 (fr) * 1983-08-01 1985-02-14 R. P. Scherer Corporation Procede de liberation entretenue et produit relatif
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
IE63179B1 (en) 1995-03-22
NZ232642A (en) 1992-07-28
NL193267B (nl) 1999-01-04
AT401727B (de) 1996-11-25
SE9000625L (sv) 1990-08-24
SE9000625D0 (sv) 1990-02-22
LU87681A1 (fr) 1991-10-08
IT1240768B (it) 1993-12-17
NL9000428A (nl) 1990-09-17
CA2010692A1 (fr) 1990-08-23
KR900012612A (ko) 1990-09-01
IL93490A0 (en) 1990-11-29
SE512412C2 (sv) 2000-03-13
ATA42190A (de) 1996-04-15
GB9004016D0 (en) 1990-04-18
KR940006271B1 (ko) 1994-07-14
IT9047659A0 (it) 1990-02-22
DE4005650C2 (de) 1999-03-25
CH680567A5 (fr) 1992-09-30
ZA901348B (en) 1991-03-27
SA90100287B1 (ar) 1999-08-15
JPH03200728A (ja) 1991-09-02
DK48090A (da) 1990-08-24
ZW1790A1 (en) 1991-10-16
PH26972A (en) 1992-12-28
GB2229094B (en) 1993-01-06
HU211930A9 (en) 1996-01-29
FR2643263A1 (fr) 1990-08-24
DK170209B1 (da) 1995-06-19
GB2229094A (en) 1990-09-19
BE1003123A3 (fr) 1991-12-03
DK48090D0 (da) 1990-02-22
HK89493A (en) 1993-09-03
JP2856817B2 (ja) 1999-02-10
IL93490A (en) 1994-07-31
AU629303B2 (en) 1992-10-01
DE4005650A1 (de) 1990-09-06
CA2010692C (fr) 1995-12-12
IE900651L (en) 1990-08-23
IT9047659A1 (it) 1991-08-22
GB8904182D0 (en) 1989-04-05
FR2643263B1 (fr) 1994-09-16
US5028432A (en) 1991-07-02
AU5007390A (en) 1990-08-30
CY1734A (en) 1994-05-06

Similar Documents

Publication Publication Date Title
NL193267C (nl) Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.
US6613353B1 (en) Pharmaceutical formulations
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
CZ290314B6 (cs) Kapalinou plněná měkká ľelatinová kapsle a způsob její výroby
JPS5989618A (ja) 無水エマルジヨンおよびその用法
CA2618705A1 (fr) Administration amelioree de tetrahydrocannabinol
WO1999006031A1 (fr) Preparation pharmaceutique pour analogues de camptothecine dans une gelule
US6352718B1 (en) Vasopressin antagonist formulation and process
US5189066A (en) Pharmaceutical compositions of tebufelone
US20040146537A1 (en) Oily wax matrix suspension formulation comprising pharmacologically active agents
EP0326103B1 (fr) Composition pharmaceutique contenant des 4-aroylimidazol-2-ones
Kane et al. A STATISTICAL MIXTURE DESIGN APPROACH FOR FORMULATING POORLY SOLUBLE COMPOUNDS IN LIQUID FILLED HARD SHELL CAPSULE
EP0431659B1 (fr) Compositions pharmaceutiques à base de tébufélone
JP4139909B2 (ja) ソフトカプセル用基剤
KR20020039354A (ko) 바소프레신 길항제 제형 및 방법
CA2310407A1 (fr) Formulations contenant de la paroxetine dissoute
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20100222